Endo International | ENDP - Capitale Di Prestito



Capitale Di Prestito Cambiamento Data
AbbVie USD 64.53B 5.59B 2026-03
ANI Pharmaceuticals USD 280.15M 5.84M 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Coherus Biosciences USD 51.08M 496K 2025-12
Eli Lilly USD 47.86B 8.49B 2026-06
Heron Therapeutics USD 140.64M 975K 2025-12
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Ligand Pharmaceuticals USD 446.9M 704K 2026-03
Merck USD 51.08B 4.41B 2026-06
Novartis USD 37.49B 42M 2026-06
Pacira USD 363.12M 4.53M 2026-06
Perrigo USD 3.28B 337.7M 2026-06
Pfizer USD 60.5B 70M 2026-06
Phibro Animal Health USD 597.68M 5.92M 2026-03
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Takeda JPY 4.42T 50.32B 2026-06
Teva Pharmaceutical Industries USD 12.09B 1.92B 2026-06
Xeris Pharmaceuticals USD 188.81M 32.42M 2026-06
Zoetis USD 9.05B 3M 2026-06